$ADVB·8-K

Advanced Biomed Inc. · Jul 1, 4:30 PM ET

Compare

Advanced Biomed Inc. 8-K

Research Summary

AI-generated summary

Updated

Advanced Biomed Inc. Reports Annual Meeting Vote Results

What Happened
Advanced Biomed Inc. (ADVB) filed an 8-K reporting the results of its annual meeting of stockholders held June 30, 2026 (10:00 a.m. ET) in Tainan City, Taiwan. Holders of 1,422,573.80 shares (≈86.105% of the 1,652,133 shares outstanding as of the May 29, 2026 record date) were present in person or by proxy, constituting a quorum. All five director nominees were elected and all five proposals were approved, including a non-binding advisory vote on named executive officer compensation ("Say-on-Pay"), an advisory vote preferring annual say-on-pay votes, and ratification of WWC, P.C. as the independent registered public accounting firm for the fiscal year ending June 30, 2026.

Key Details

  • Meeting date/location: June 30, 2026 at No. 689-85 Xiaodong Road, Yongkang District, Tainan City, Taiwan. Record date: May 29, 2026.
  • Votes cast (presence/proxy): 1,422,573.80 shares, representing ~86.105% of outstanding common stock.
  • Directors elected (for / against / abstain / broker non-votes):
    • Xiaomin Chen: 1,296,710.80 / 49,755.00 / 0.00 / 76,108.00
    • Mingze Yin: 1,346,466.80 / 0.00 / 0.00 / 76,107.00
    • Jing Zhang: 1,346,460.80 / 5.00 / 0.00 / 76,108.00
    • Cheang I Kei: 1,346,460.80 / 5.00 / 0.00 / 76,108.00
    • Mingyue Cai: 1,346,460.80 / 5.00 / 0.00 / 76,108.00
  • Other proposals: Say-on-Pay approved 1,346,420.80 for / 45.00 against; advisory frequency vote favored one year (1,346,420.60 votes); WWC, P.C. ratified as auditor 1,422,573.80 for; adjournment approved 1,422,537.80 for.

Why It Matters
The results confirm board continuity with all five nominees elected and show strong shareholder support for management on executive compensation (advisory) and annual frequency for future say-on-pay votes. Ratifying WWC, P.C. as auditor finalizes the company’s independent accounting firm for FY2026. High turnout (~86%) and the vote tallies give investors clear signals about shareholder alignment with corporate governance and oversight choices disclosed in the company’s proxy statement.

Loading document...